Personal Importation Exemptions Scope

Introduction

Personal importation exemptions are legal provisions that permit individuals to import limited quantities of certain goods for personal use without complying with every requirement applicable to commercial imports. In pharmaceutical and biotechnology law, these exemptions can be important for patients who need medicines unavailable in their home country.

In India, personal importation is governed by the applicable provisions of the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and customs legislation. Personal use does not automatically exempt an import from licensing requirements, customs duties or product-specific restrictions.

CDSCO

+2

Legal Framework and Scope

Rule 36 of the Drugs and Cosmetics Rules, 1945, provides a route for importing certain small quantities of drugs for personal use.

Personal baggage: Drugs may qualify where they form part of a passenger’s bona fide baggage, belong to the passenger and are intended exclusively for that person’s use.

Quantity restrictions: The general limit under Rule 36 is 100 average doses of any single drug. The licensing authority may permit a larger quantity in an exceptional individual case.

Imports outside personal baggage: An applicant may seek permission under Rule 36 by submitting Form 12A, supported by a prescription from a registered medical practitioner. If the conditions are satisfied, the relevant authority may grant a permit in Form 12B.

Customs compliance: A drug import exemption does not necessarily remove customs duty or declaration requirements. Customs treatment depends on the applicable notifications and conditions.

Public-health restrictions: Personal importation cannot be assumed to override specific prohibitions or requirements applicable to particular drugs.

The Central Drugs Standard Control Organisation (CDSCO) provides a dedicated procedure for applications to import small quantities of drugs for personal use.

CDSCO

+2

Important Case Laws

1. Commissioner of Customs v. Dilip Kumar and Company (2018) 9 SCC 1

The Constitution Bench of the Supreme Court held that a person claiming an exemption must establish eligibility under the relevant exemption provision. Where an exemption notification is genuinely ambiguous, the Court explained that the ambiguity is generally resolved in favour of the Revenue. This principle is relevant to claims for customs-duty exemptions involving personal imports, although the case did not specifically concern Rule 36.

2. Novartis AG v. Union of India (2013) 6 SCC 1

The Supreme Court examined pharmaceutical patentability under Section 3(d) of the Patents Act, 1970. Although the case concerned patents rather than personal importation, it demonstrates that pharmaceutical regulation and access to medicines operate within defined statutory limits. It does not establish a personal-import exemption.

3. Union of India v. Sanjeev Woollen Mills (1998) 9 SCC 647

The Supreme Court considered customs valuation and the application of customs law to imported goods. The decision illustrates that the treatment of imported goods depends on the governing statutory provisions and the relevant facts. It is relevant to the broader customs framework, but it is not a direct ruling on Rule 36.

Conclusion

Personal importation exemptions facilitate individual access to necessary medicines while maintaining safeguards for product quality, patient safety and customs administration. In India, Rule 36 provides a conditional route for qualifying personal imports, including prescribed procedures for medicines that are not carried in personal baggage. Applicants must establish eligibility, obtain the required permit where applicable and comply with customs and other legal requirements. The scope of any exemption must be determined from the specific statutory provision rather than from the personal nature of the purchase alone.